GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (STU:CJH) » Definitions » Other Current Liabilities

CanSino Biologics (STU:CJH) Other Current Liabilities : €58.11 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CanSino Biologics Other Current Liabilities?

CanSino Biologics's other current liabilities for the quarter that ended in Dec. 2024 was €58.11 Mil.

CanSino Biologics's quarterly other current liabilities declined from Mar. 2024 (€70.66 Mil) to Jun. 2024 (€10.52 Mil) but then increased from Jun. 2024 (€10.52 Mil) to Dec. 2024 (€58.11 Mil).

CanSino Biologics's annual other current liabilities declined from Dec. 2022 (€64.40 Mil) to Dec. 2023 (€21.84 Mil) but then increased from Dec. 2023 (€21.84 Mil) to Dec. 2024 (€58.11 Mil).


CanSino Biologics Other Current Liabilities Historical Data

The historical data trend for CanSino Biologics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Other Current Liabilities Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only 10.74 46.62 64.40 21.84 58.11

CanSino Biologics Quarterly Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.89 21.84 70.66 10.52 58.11

CanSino Biologics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


CanSino Biologics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


CanSino Biologics Business Description

Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

CanSino Biologics Headlines

No Headlines